ASTELIN Trademark

Trademark Overview

On Thursday, June 6, 2024, a trademark application was filed for ASTELIN with the United States Patent and Trademark Office. The USPTO has given the ASTELIN trademark a serial number of 98588595. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, August 7, 2025. This trademark is owned by Rising Pharma Holdings, Inc.. The ASTELIN trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines
astelin

General Information

Serial Number98588595
Word MarkASTELIN
Filing DateThursday, June 6, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, August 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAntihistamines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRising Pharma Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2024ASSIGNED TO EXAMINER
Wednesday, December 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024NON-FINAL ACTION WRITTEN
Monday, March 17, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, March 17, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, June 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 18, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, June 18, 2025SUSPENSION LETTER WRITTEN
Wednesday, June 18, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 7, 2025ASSIGNED TO LIE
Thursday, August 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 2, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Related Keywords

astelin antihistamines